Australia markets close in 5 hours 52 minutes

CVS Health Corporation (CVS)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
64.70-0.29 (-0.45%)
At close: 4:00PM EDT

64.70 0.00 (0.00%)
After hours: 7:49PM EDT

Currency in USD

Valuation measures

Market cap (intra-day) 584.67B
Enterprise value 3159.59B
Trailing P/E 10.28
Forward P/E 18.59
PEG ratio (5-yr expected) 11.42
Price/sales (ttm)0.32
Price/book (mrq)1.24
Enterprise value/revenue 30.61
Enterprise value/EBITDA 68.74

Trading information

Stock price history

Beta (5Y monthly) 0.70
52-week change 310.45%
S&P500 52-week change 318.71%
52-week high 377.03
52-week low 352.04
50-day moving average 364.03
200-day moving average 363.65

Share statistics

Avg vol (3-month) 37.29M
Avg vol (10-day) 37.7M
Shares outstanding 51.31B
Float 1.31B
% held by insiders 10.19%
% held by institutions 179.64%
Shares short (30 Jul 2020) 419.91M
Short ratio (30 Jul 2020) 43.07
Short % of float (30 Jul 2020) 41.52%
Short % of shares outstanding (30 Jul 2020) 41.52%
Shares short (prior month 29 Jun 2020) 417.98M

Dividends & splits

Forward annual dividend rate 42
Forward annual dividend yield 43.08%
Trailing annual dividend rate 32.00
Trailing annual dividend yield 33.08%
5-year average dividend yield 42.56
Payout ratio 431.80%
Dividend date 302 Aug 2020
Ex-dividend date 421 Jul 2020
Last split factor 22:1
Last split date 306 Jun 2005

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2019
Most-recent quarter (mrq)29 Jun 2020


Profit margin 3.14%
Operating margin (ttm)5.28%

Management effectiveness

Return on assets (ttm)3.82%
Return on equity (ttm)12.73%

Income statement

Revenue (ttm)262.98B
Revenue per share (ttm)201.52
Quarterly revenue growth (yoy)3.20%
Gross profit (ttm)44.52B
Net income avi to common (ttm)8.26B
Diluted EPS (ttm)6.29
Quarterly earnings growth (yoy)53.70%

Balance sheet

Total cash (mrq)17.46B
Total cash per share (mrq)13.35
Total debt (mrq)92.05B
Total debt/equity (mrq)134.67
Current ratio (mrq)0.98
Book value per share (mrq)52.04

Cash flow statement

Operating cash flow (ttm)15.99B
Levered free cash flow (ttm)13.07B